Loading clinical trials...
Loading clinical trials...
Phase 1/2 Study of CORT125134 in Combination With Nab-paclitaxel in Patients With Solid Tumors
Conditions
Interventions
Relacorilant with nab-paclitaxel
Locations
4
United States
038
Scottsdale, Arizona, United States
014
San Francisco, California, United States
001
Chicago, Illinois, United States
013
Ogden, Utah, United States
Start Date
May 23, 2016
Primary Completion Date
May 12, 2020
Completion Date
September 12, 2020
Last Updated
December 6, 2022
NCT06898450
NCT06658951
NCT05719558
NCT05101070
NCT06307795
NCT06716138
Lead Sponsor
Corcept Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions